Literature DB >> 8342796

Should we use muscle biopsy to diagnose malignant hyperthermia susceptibility?

M G Larach.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8342796     DOI： 10.1097/00000542-199307000-00002

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  4 in total

1.  Should patients with central core disease be screened for malignant hyperthermia?

Authors:  P J Halsall; L R Bridges; F R Ellis; P M Hopkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 2.  Malignant hyperthermia.

Authors:  R Ben Abraham; P Adnet; V Glauber; A Perel
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

Review 3.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

4.  Diagnosis of malignant hyperthermia: a comparison of the in vitro contracture test with the molecular genetic diagnosis in a large pedigree.

Authors:  J M Healy; K A Quane; K E Keating; M Lehane; J J Heffron; T V McCarthy
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.